|
1
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to Occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kikkawa N, Hanazawa T, Fujimura L, Nohata
N, Suzuki H, Chazono H, Sakurai D, Horiguchi S, Okamoto Y and Seki
N: miR-489 is a tumour-suppressive miRNA target PTPN11 in
hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer.
103:877–884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nohata N, Hanazawa T, Kikkawa N, Sakurai
D, Fujimura L, Chiyomaru T, Kawakami K, Yoshino H, Enokida H,
Nakagawa M, et al: Tumour suppressive microRNA-874 regulates novel
cancer networks in maxillary sinus squamous cell carcinoma. Br J
Cancer. 105:833–841. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nohata N, Hanazawa T, Kinoshita T, Inamine
A, Kikkawa N, Itesako T, Yoshino H, Enokida H, Nakagawa M, Okamoto
Y, et al: Tumour-suppressive microRNA-874 contributes to cell
proliferation through targeting of histone deacetylase 1 in head
and neck squamous cell carcinoma. Br J Cancer. 108:1648–1658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukumoto I, Kinoshita T, Hanazawa T,
Kikkawa N, Chiyomaru T, Enokida H, Yamamoto N, Goto Y, Nishikawa R,
Nakagawa M, et al: Identification of tumour suppressive
microRNA-451a in hypopharyngeal squamous cell carcinoma based on
microRNA expression signature. Br J Cancer. 111:386–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fukumoto I, Hanazawa T, Kinoshita T,
Kikkawa N, Koshizuka K, Goto Y, Nishikawa R, Chiyomaru T, Enokida
H, Nakagawa M, et al: MicroRNA expression signature of oral
squamous cell carcinoma: Functional role of microRNA-26a/b in the
modulation of novel cancer pathways. Br J Cancer. 112:891–900.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar
|
|
15
|
Kinoshita T, Hanazawa T, Nohata N, Okamoto
Y and Seki N: The functional significance of microRNA-375 in human
squamous cell carcinoma: Aberrant expression and effects on cancer
pathways. J Hum Genet. 57:556–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Isozaki Y, Hoshino I, Nohata N, Kinoshita
T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N,
et al: Identification of novel molecular targets regulated by tumor
suppressive miR-375 induced by histone acetylation in esophageal
squamous cell carcinoma. Int J Oncol. 41:985–994. 2012.PubMed/NCBI
|
|
17
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar
|
|
18
|
Matsushita R, Yoshino H, Enokida H, Goto
Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M and Seki N:
Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145
(miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell
aggressiveness. Oncotarget. 7:28460–28487. 2016.PubMed/NCBI
|
|
19
|
Goto Y, Kojima S, Nishikawa R, Kurozumi A,
Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M,
et al: MicroRNA expression signature of castration-resistant
prostate cancer: The microRNA-221/222 cluster functions as a tumour
suppressor and disease progression marker. Br J Cancer.
113:1055–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kita Y, Nishizono Y, Okumura H, Uchikado
Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, et
al: Clinical and biological impact of cyclin-dependent kinase
subunit 2 in esophageal squamous cell carcinoma. Oncol Rep.
31:1986–1992. 2014.PubMed/NCBI
|
|
22
|
Brinckerhoff CE, Rutter JL and Benbow U:
Interstitial collagenases as markers of tumor progression. Clin
Cancer Res. 6:4823–4830. 2000.
|
|
23
|
Yan JW, Lin JS and He XX: The emerging
role of miR-375 in cancer. Int J Cancer. 135:1011–1018. 2014.
View Article : Google Scholar
|
|
24
|
Hui AB, Bruce JP, Alajez NM, Shi W, Yue S,
Perez-Ordonez B, Xu W, O'Sullivan B, Waldron J, Cummings B, et al:
Significance of dysregulated metadherin and microRNA-375 in head
and neck cancer. Clin Cancer Res. 17:7539–7550. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z, Hong Z, Gao F and Feng W:
Upregulation of microRNA-375 is associated with poor prognosis in
pediatric acute myeloid leukemia. Mol Cell Biochem. 383:59–65.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szczyrba J, Nolte E, Wach S, Kremmer E,
Stöhr R, Hartmann A, Wieland W, Wullich B and Grässer FA:
Downregulation of Sec23A protein by miRNA-375 in prostate
carcinoma. Mol Cancer Res. 9:791–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kinoshita T, Yip KW, Spence T and Liu FF:
MicroRNAs in extracellular vesicles: Potential cancer biomarkers. J
Hum Genet. Jul 7–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yonemori K, Kurahara H, Maemura K and
Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. Jun
2–2016.(Epub ahead of print). View Article : Google Scholar
|
|
29
|
Knäuper V, López-Otin C, Smith B, Knight G
and Murphy G: Biochemical characterization of human collagenase-3.
J Biol Chem. 271:1544–1550. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vincenti MP and Brinckerhoff CE:
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: Integration of complex signaling pathways for the
recruitment of gene-specific transcription factors. Arthritis Res.
4:157–164. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Etoh T, Inoue H, Yoshikawa Y, Barnard GF,
Kitano S and Mori M: Increased expression of collagenase-3 (MMP-13)
and MT1-MMP in oesophageal cancer is related to cancer
aggressiveness. Gut. 47:50–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration, and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu D, Ding J, Wang L, Pan H, Zhou Z, Zhou
J and Qu P: microRNA-125b inhibits cell migration and invasion by
targeting matrix metallopeptidase 13 in bladder cancer. Oncol Lett.
5:829–834. 2013.PubMed/NCBI
|
|
34
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu J, Mao Y, Zhang D, Hao S, Zhang Z, Li
Z and Li B: MiR-143 inhibits tumor cell proliferation and invasion
by targeting STAT3 in esophageal squamous cell carcinoma. Cancer
Lett. 373:97–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuen KW, Montpetit B and Hieter P: The
kinetochore and cancer: What's the connection? Curr Opin Cell Biol.
17:576–582. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sagona AP and Stenmark H: Cytokinesis and
cancer. FEBS Lett. 584:2652–2661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rath O and Kozielski F: Kinesins and
cancer. Nat Rev Cancer. 12:527–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huszar D, Theoclitou ME, Skolnik J and
Herbst R: Kinesin motor proteins as targets for cancer therapy.
Cancer Metastasis Rev. 28:197–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aytes A, Mitrofanova A, Lefebvre C,
Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A,
Pienta KJ, Shen MM, et al: Cross-species regulatory network
analysis identifies a synergistic interaction between FOXM1 and
CENPF that drives prostate cancer malignancy. Cancer Cell.
25:638–651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu C, Zhao J, Bibikova M, Leverson JD,
Bossy-Wetzel E, Fan JB, Abraham RT and Jiang W: Functional analysis
of human microtubule-based motor proteins, the kinesins and
dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol
Cell. 16:3187–3199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Corson TW, Zhu CQ, Lau SK, Shepherd FA,
Tsao MS and Gallie BL: KIF14 messenger RNA expression is
independently prognostic for outcome in lung cancer. Clin Cancer
Res. 13:3229–3234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thériault BL, Pajovic S, Bernardini MQ,
Shaw PA and Gallie BL: Kinesin family member 14: An independent
prognostic marker and potential therapeutic target for ovarian
cancer. Int J Cancer. 130:1844–1854. 2012. View Article : Google Scholar
|
